Fountain Life.

The thesis

Fountain Life was built on a single editorial bet: that the most important medical event of your next decade is a finding you don’t yet have, that imaging and genomics can surface earlier than symptoms, and that a network of well-resourced clinics can detect it. We agree with the thesis. The execution is, in 2026, among the most technologically capable in the United States.

The Naples founding clinic, plus Orlando, Dallas, Westchester (White Plains, NY) and Houston, run the CORE Diagnostics workup, listed at $10,500 on the official shop: whole-body MRI with AI-augmented reading, coronary CT angiography with AI, whole-genome sequencing, 100+ blood markers, low-dose lung CT, retinal and skin-cancer screening, DEXA, VO₂ max, multi-cancer detection. Miami (One Thousand Museum) is opening next, with Los Angeles announced for autumn 2027. Co-founder Dr. William Kapp is CEO; Dr. Dawn Mussallem leads as Chief Medical Officer. The technology stack is genuinely state-of-the-art. The clinicians are real.

What you get

The detection day is rigorous. Three things stand out from the workups we’ve audited.

The cardiac imaging is unusually deep — coronary CT angiography with AI-augmented reading rather than calcium scoring alone. For a US-based reader with cardiac family history, this is meaningfully more than the typical executive physical produces.

The MRI reading benefits from the AI augmentation in a way the marketing implies and the clinical practice substantiates: incidental findings are flagged and triaged faster than at the typical hospital radiology desk.

The genomic component is real whole-genome sequencing, not a SNP chip — which most longevity clinics quietly substitute for the headline service.

The conflict question

Where Fountain Life loses points relative to YEARS or Biograph: the financial geometry of the APEX membership.

Above CORE, the natural next step the clinic offers — and which the marketing structure encourages — is the APEX membership, listed at $23,500 a year on the official shop. APEX is real concierge medicine: ongoing care team, year-round follow-up, protocol design. Around it, the shop sells IV infusions, placental stem-cell IV therapy, therapeutic plasma exchange ($10,000), ‘Restorative Biologics’ labelled as not FDA-approved, orthobiologics and aesthetics.

This is the structural pattern we deduct points for. The clinic that ran the workup is also the clinic billing for the year of treatments downstream. The arrangement is not unusual in American medicine — it is, in fact, the executive-medicine norm — but it sits in tension with editorial independence on what a finding actually warrants.

We score the diagnostic strongly. We score the conflict structure honestly.

Where it falls short

Three honest caveats.

The regenerative and stem-cell-adjacent treatments offered at certain locations sit in evidence territory we believe deserves stronger labelling than the current marketing provides. The clinicians in conversation are appropriately conservative; the website is less so.

An APEX year costs $23,500 before any add-on treatment — comparable to a Swiss residential week, with a different value proposition. We are not sure the comparison consistently favours Fountain Life.

The brand voice — Diamandis, Robbins, abundance — runs warmer than the editorial tone the field arguably needs. We mention this because we have heard it from readers.

The verdict

For the US-based reader who wants a state-of-the-art detection day under a single well-resourced roof, Fountain Life is the strongest network option we currently rank. Where it does not lead — and where YEARS and Biograph do — is on the question of what business model the diagnostic feeds into.

Detection is hard, expensive, and worth doing well. Selling treatments to the patient you just detected is also hard, but for different reasons.

Questions readers ask about Fountain Life

— 01

How much does Fountain Life cost?

Pricing for Fountain Life, as checked in September 2026: BASE membership at $595 per year; CORE Diagnostics at $10,500 per year; APEX membership at $23,500 per year.

— 02

Does Fountain Life earn from the treatments it recommends?

Yes. We score this as a structural conflict of interest. Diagnostic findings flow into in-house memberships and treatments: the official shop sells APEX ($23,500), IV infusions, placental stem-cell IV therapy and therapeutic plasma exchange. The same business unit profits from the workup and the year of follow-up treatments that result. Fountain Life scores 18/25 on conflict freedom.

— 03

Is Fountain Life physician-led?

Yes. Medical leadership: Dr. Dawn Mussallem, DO (Chief Medical Officer). Fountain Life scores 22/25 on medical supervision.

— 04

How does Fountain Life rank among longevity clinics?

Fountain Life ranks #6 of 19 in the 2026 Longevity Clinics ranking, with 85/100 (Excellent). Heavy on diagnostic technology, lighter on independence. Worth the cheque for the patient who wants a single American flagship under one well-resourced roof.